by Lindsey Drake | Apr 3, 2023 | Clinical, Molecular
This blog post is the third in our Optimal QC in the Clinical Laboratory series. Previously, in this series we highlighted the importance of external and third-party quality control products in the clinical laboratory, emphasizing that quality control, by design,...
by Lindsey Drake | Apr 3, 2023 | Clinical, Molecular
This blog post is the second in our Optimal QC in the Clinical Laboratory series. In a previous blog post, we highlighted the importance of external quality control products for QC in the clinical laboratory, rather than relying solely on internal controls built into...
by Lindsey Drake | Mar 30, 2023 | Clinical, Molecular
This post on external quality controls is the first in our series on Optimal QC in the Clinical Laboratory, which also covers third-party controls and IVD labelled controls. By principle, quality control (QC) in the clinical laboratory must subject all...
by Andrea Marra | Dec 14, 2022 | Molecular, SARS-CoV-2
Perhaps you have heard that we could be facing a potential “tridemic,” with SARS-CoV-2 (COVID-19), Flu A/B, and a lesser-known third virus–respiratory syncytial virus, or RSV–set to be swirling around us at the same time in the fall/winter of 2022 – 2023. RSV has...
by Microbiologics | Dec 1, 2022 | Clinical, Molecular
An Interview with Julie Laramie, MS-CLS, MLS (ASCP)CM, SMCM Significant technological advancements have changed the world of clinical diagnostics. For instance, the application of molecular biology to clinical microbiology has decreased turn-around-times for some...
by Mackenzie Forseth | Aug 19, 2022 | Clinical, Molecular
Human papillomavirus (HPV) is the most common sexually transmitted infection (STI), in part because many experience no symptoms, so it is unknowingly passed between partners. This is why it is considered to be the “silent STI.” HPV is a viral infection that may result...
